CCM
NNVC icon

Connective Capital Management’s NanoViricides NNVC Stock Holding History

Connective Capital Management’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$256K Buy
+185,217
New +$254K 0.18% 46

Other funds holding NNVC

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MFS
Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Connective Capital Management's NNVC Position: Q2 2026 in Review

Connective Capital Management opened a new position in NanoViricides (NNVC) in Q2 2026: 185,217 shares worth $256K. The stake represents 0.18% of the portfolio and ranks #46 among its holdings.

37 funds tracked by Wall St. Rank hold NNVC as of Q2 2026.

  • Connective Capital Management held 185,217 shares of NanoViricides worth $256K as of Q2 2026.
  • NanoViricides was a new Connective Capital Management position in Q2 2026.
  • NanoViricides made up 0.18% of Connective Capital Management's portfolio in Q2 2026, its #46 holding.
  • 37 funds tracked by Wall St. Rank held NanoViricides as of Q2 2026.

Based on Connective Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.